Circulating Inflammation Signature Predicts Overall Survival and Relapse-Free Survival in Metastatic Colorectal Cancer

British Journal of Cancer - United Kingdom
doi 10.1038/s41416-018-0360-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A Seven-Gene Signature Predicts Overall Survival of Patients With Colorectal Cancer

Oncotarget
Oncology
2016English

Triple-Negative Subtype Predicts Poor Overall Survival and High Locoregional Relapse in Inflammatory Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
2011English

Hypertension and Overall Survival in Metastatic Colorectal Cancer Patients Treated With Bevacizumab-Containing Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
2011English

Lymphopenia Combined With Low TCR Diversity (Divpenia) Predicts Poor Overall Survival in Metastatic Breast Cancer Patients

OncoImmunology
OncologyAllergyImmunology
2012English

High HSF4 Expression Is an Independent Indicator of Poor Overall Survival and Recurrence Free Survival in Patients With Primary Colorectal Cancer

IUBMB Life
BiochemistryGeneticsClinical BiochemistryCell BiologyMolecular Biology
2017English

Immunoglobulin Kappa C Predicts Overall Survival in Node-Negative Breast Cancer

PLoS ONE
Multidisciplinary
2012English

Cyclin D3 Predicts Disease-Free Survival in Breast Cancer

Cancer Cell International
Cancer ResearchOncologyGenetics
2015English

Figure 2: The Nine-lncRNA Prognostic Signature to Predict the Overall Survival of Colorectal Cancer Patients.

English

Overall Survival and Second Primary Malignancies in Men With Metastatic Prostate Cancer

PLoS ONE
Multidisciplinary
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy